Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03174
Species: Homo sapiens
Position : chr6:45333183-45333484
Year: 2025
Title: Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: acute lymphoblastic leukemia
PMID:  40729681
MONDO: MONDO:0004967
Tissue: bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: Primary human KMT2A::AFF1 ALL blast
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; Chromatin interaction assay; Functional perturbation assay
High Throughput Method: scMultiome ATAC+RNA; H3K27ac CUT&Tag; Micro-Capture-C; single-cell multiome; Micro Capture-C; chromatin profiling
Low Throughput Method: CRISPR enhancer deletion; RT-qPCR
About Target Gene
Target gene : RUNX2
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer